Mobile Site ›

Clopidogrel Platelet Function Tests

Caveats and Controversies



Subscribe

Receive notification when new Hot Topics are published:

FDA Answer

Slide 35

December 2011

The FDA replied that they were not making any recommendation concerning the use of genetic testing; they were only informing health care professionals that such genetic testing is available to identify CYP2C19 polymorphisms and were leaving genetic testing decisions up to the practitioner’s professional judgment.

FDA Answer

 


Jump to section:


Key